| Proteomics-metabolomics combined approach identifies peroxidasin as a protector against metabolic and oxidative stress in prostate cancer J Dougan, O Hawsawi, LJ Burton, G Edwards, K Jones, J Zou, ... International Journal of Molecular Sciences 20 (12), 3046, 2019 | 39 | 2019 |
| Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer X Li, L Gera, S Zhang, Y Chen, L Lou, LM Wilson, ZR Xie, G Sautto, D Liu, ... Theranostics 11 (14), 6873, 2021 | 23 | 2021 |
| SNAIL Transctiption factor in prostate cancer cells promotes neurite outgrowth G Edwards, T Campbell, V Henderson, A Danaher, D Wu, R Srinivasan, ... Biochimie 180, 1-9, 2021 | 9 | 2021 |
| Overcoming prostate cancer drug resistance with a novel organosilicon small molecule R Zhao, X Ma, L Bai, X Li, K Mamouni, Y Yang, HY Liu, A Danaher, ... Neoplasia 23 (12), 1261-1274, 2021 | 8 | 2021 |
| Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models L Bai, X Li, Y Yang, R Zhao, EZ White, A Danaher, NJ Bowen, CV Hinton, ... Translational Oncology 34, 101707, 2023 | 4 | 2023 |
| Novel small‐molecule LG1836 inhibits the in vivo growth of castration‐resistant prostate cancer Y Chen, X Li, K Mamouni, Y Yang, A Danaher, J White, HY Liu, O Kucuk, ... The Prostate 80 (12), 993-1005, 2020 | 3 | 2020 |
| Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models X Li, Y Chen, L Bai, R Zhao, Y Wu, ZR Xie, JM Wu, NJ Bowen, A Danaher, ... British Journal of Cancer 129 (5), 884-894, 2023 | 2 | 2023 |
| A novel Skp1 inhibitor has potent preclinical efficacy against metastatic castration-resistant prostate cancer X Li, K Mamouni, R Zhao, Y Wu, ZR Xie, G Sautto, D Liu, N Bowen, ... Cancer Research 83 (7_Supplement), 519-519, 2023 | | 2023 |
| Repositioning nicardipine as a novel targeted therapy for chemoresistant prostate cancer X Li, A Danaher, JM Wu, Y Wu, ZR Xie, N Cook, N Bowen, D Wu Cancer Research 82 (12_Supplement), 5365-5365, 2022 | | 2022 |
| Downregulation of Epithelial Protein Lost in Neoplasm (EPLIN) is Associated with Aggressive Prostate Cancer at the Protein and Transcriptomic Levels D Wu, A Danaher, AO Osunkoya LABORATORY INVESTIGATION 101 (SUPPL 1), 628-629, 2021 | | 2021 |
| Aberrantly increased expression of ZIC2 is correlated with altered cellular metabolism in prostate cancer NJ Bowen, A Danaher Cancer Research 79 (13_Supplement), 787-787, 2019 | | 2019 |
| Establishment of CRISPR/Cas9-Aided Knockout of the ZIC2 gene in the African American Prostate Cancer Cell Line E006AA-Pr. JC Moore, A Danaher, N Bowen PhD Georgia Journal of Science 77 (1), 8, 2019 | | 2019 |
| Gene dosage of ZIC family member 2 affects proliferation of prostate cancer cells KC Davis, A Danaher, NJ Bowen MOLECULAR BIOLOGY OF THE CELL 26, 2015 | | 2015 |
